About the Diabetes Risk Panel
with Score

What is it?

The Diabetes Risk Panel with Score predicts a patient’s risk of developing diabetes. It provides four components:

When should you use it?

  • To assess a patient’s risk of developing diabetes
  • To identify prediabetes

What makes it different?

This panel offers some key advantages that directly impact the quality of information and care you can provide to your patients early on:

  • Measures both glucose and HbA1c levels—recent studies have shown that testing glucose plus HbA1c levels provides greater accuracy in identifying prediabetes than testing either marker alone1-4
  • Offers 8-Year Framingham Diabetes Risk Score—optional and available at no additional cost, this score is based on the landmark Framingham Study Group and provides a percentage risk of developing diabetes over the next 8 years5
  • Reports results in a graphical format—supports your discussions with patients by helping you clearly communicate risk

Get more details on the Diabetes Risk Panel with Score, or find out more about other risk assessment tests such as the Diabetes Risk Panel without Score, which does not have the 8-Year Framingham Diabetes Risk Score.

Next, read about the Diabetes, Newly Diagnosed and Monitoring Panel

Let us help you know what’s ahead

Contact a Quest Diagnostics sales representative to learn more
1.866.MYQUEST (1.866.697.8378)

Want to learn more about ADA guidelines-based testing?
Watch the webinar

View sample report

1 Schöttker B, Raum E, Rothenbacher D, et al. Prognostic value of haemoglobin
   A1c and fasting plasma glucose for incident diabetes and implications for screening. Eur J Epidemiol.
   2011;26:779-787.

2 Sato KK, Hayashi T, Harita N, et al. Combined measurement of fasting plasma glucose
   and A1c is effective for the prediction of type 2 diabetes. The Kansai Healthcare Study.
   Diabetes Care. 2009;32:644-646.

3 Soulimane S, Simon D, Shaw J, et al. HbA1c, fasting plasma glucose
   and the prediction of diabetes: Inter99, AusDiab and D.E.S.I.R. Diab Res Clin Pract. 2012;96:392-399.

4 Wang W, Lee ET, Howard BV, et al. Fasting plasma glucose and hemoglobin
   A1c in identifying and predicting diabetes. Diabetes Care. 2011;34:363-368.

5 Leong A, Daya N, Porneala B, et al. Prediction of type 2 diabetes by hemoglobin
   A1c in two community-based cohorts. Diabetes Care. 2018;41(1):60-68.